Regina Salvat, Ph.D.

Regina Salvat, PhD, is a Principal at Forbion. She joined Forbion from Sofinnova Investments, where she has been driving multiple successful, private investments. She has a PhD in protein engineering from Dartmouth College, and a degree in Biomedical engineering from Cornell University.

Regina has already collaborated with Forbion on a number of successful investments, including Gyroscope and Capstan Therapeutics. At Forbion, Regina concentrates on Growth strategies building on her extensive experience and network. She currently serves on the board of Marea Therapeutics.